The A.L.P.H.A. initiative progresses with local partnerships, veterinary training, and responding to emerging disease
Two academics, a student, and one of the world’s most distinguished veterinarians are embarking on four separate research projects to promote small animal health and fight rabies in Africa. These projects are all being undertaken in conjunction with the African Small Companion Animal Network (AFSCAN). AFSCAN was co-founded by Zoetis, the World Small Animal Veterinary Association Foundation (WSAVA) and other animal health organizations in 2014 to advance standards of veterinary care across Africa and to help combat rabies.
Dr. Mahesh Kumar, Vice President, Global Biological Research and Development at Zoetis shares his insights on taking a One Health approach to combating emerging infectious diseases.
At Zoetis, we understand the special bond shared between people and their pets – and the importance of keeping our canine companions happy and healthy. Today we will focus on how we care for dogs from a dermatology perspective, just one of the many core areas of focus for Zoetis.
New infectious diseases and new subtypes of ever-present diseases are constantly emerging. These diseases can affect animals and people alike. Zoetis is at the forefront of the battle to combat bacteria and viruses threatening animal health.
The Zoetis for Shelters program provides exceptional discounts on many of the Zoetis products that shelters use most. The average shelter saves $4,592 a year. This money saved can instead go towards helping more pets find forever homes.
Today, Zoetis was named one of America’s Best Midsize Employers in 2016 by Forbes Magazine. Zoetis is the only pharmaceutical company focused solely on animal health to make the list, and is ranked #81 out of 250 midsize companies.
Kristin Peck, Executive Vice President and President, U.S. Operations, shares her insights on the importance of antibiotic stewardship.
Karen Stasiak, Area Veterinarian for Zoetis, volunteers each year for the annual Can-AM Crown Sled Dog Race.
The U.S. Food and Drug Administration (FDA) has approved Simparica™, a once-monthly chewable flea and tick medication for dogs.
Clinton Lewis, executive vice president and president, International Operations at Zoetis, has been recognized by Savoy magazine as one of 2016’s Top 100 Most Influential African-Americans in Corporate America. He joins some of the nation’s most seasoned executives and business leaders, who were honored based on exemplary accomplishments and influence.
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.